657 Characterization and therapeutic targeting of a tumor-associated tolerogenic DC subpopulation driven by SREBP2 and the mevalonate metabolic pathway

• Fang Liu,
• Brent Hanks,
• Georgia Beasley,
• Nicholas DeVito,
• Michael Plebanek,
• Balamayooran Theivanthiran

Affiliations

Fang Liu

Department of Ultrasound, Peking University People`s Hospital, Beijing, China

Brent Hanks

Aff630 grid.26009.3d0000000419367961Duke Cancer Institute Durham NC USA

Georgia Beasley

1Duke University, DURHAM, NC, USA

Nicholas DeVito

Oxford University, Oxford, UK

Michael Plebanek

Duke University, Durham, NC, United States

Balamayooran Theivanthiran

Duke University, Durham, NC, United States